We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,946.00
Bid: 10,952.00
Ask: 10,954.00
Change: 32.00 (0.29%)
Spread: 2.00 (0.018%)
Open: 10,914.00
High: 10,954.00
Low: 10,764.00
Prev. Close: 10,914.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

23 Nov 2020 12:05

FOREX-Vaccine developments keep dollar down; Kiwi hits 2-year high

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E (Updates prices, adds comment and chart)By Elizabeth HowcroftLONDON, Nov 23 (Reuters) - Risk appetite in currency markets was boosted by progress towards a COVID-19 vaccine rollout even a...

Read more
23 Nov 2020 11:21

LIVE MARKETS-2021: UK stocks' time... but with a Brexit deal

* European shares hit highest since end February* AstraZeneca COVID-19 vaccine can be 90% effective* Vaccine shots could reach Americans by mid-December* Eurozone business activity shrink sharply in November* STOXX off highs, up 0.5%; S&P 500 e-minis...

Read more
23 Nov 2020 10:18

EMERGING MARKETS-Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes

* Markets shrug off ratings downgrade on S.Africa* EM stocks hit new 32-month highs* Vaccine hopes boost global mood* Lira bucks trend with almost 2% fallBy Sruthi ShankarNov 23 (Reuters) - The South African rand jumped on Monday despite a pair of s...

Read more
23 Nov 2020 10:12

LIVE MARKETS-Poor PMIs: no worries it's Vaccine Monday!

* European shares hit highest since end February* AstraZeneca COVID-19 vaccine can be 90% effective* Vaccine shots could reach Americans by mid-December* Eurozone business activity shrink sharply in November* STOXX off highs, up 0.5%; S&P 500 e-minis...

Read more
23 Nov 2020 10:10

UPDATE 2-European shares slip as jump in virus cases offsets vaccine hopes

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* AstraZeneca drops as vaccine efficacy rate lower than peers* Euro zone business activity falls sharply in November* Cineworld surges on ad...

Read more
23 Nov 2020 10:01

Some signs AstraZeneca vaccine durability could be a year -chief investigator

LONDON, Nov 23 (Reuters) - Scientists testing the efficacy of AstraZeneca's experimental COVID-19 vaccine said they cannot be sure if the virus will mutate in a way that would make it necessary to repeat vaccination every year, but that for now t...

Read more
23 Nov 2020 09:57

UPDATE 2-AstraZeneca vaccine news drags on FTSE, but mid-caps immune

* AstraZeneca marks worst day in nearly six months* UK aims to roll out a COVID-19 vaccine before Christmas* Cineworld jumps on securing additional debt (Updates to close)By Devik Jain and Ambar WarrickNov 23 (Reuters) - British stocks rose on optim...

Read more
23 Nov 2020 09:55

LIVE MARKETS-More sceptics on the EU recovery fund

* European shares hit highest since end February* AstraZeneca COVID-19 vaccine can be 90% effective* Vaccine shots could reach Americans by mid-December Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You ...

Read more
23 Nov 2020 09:53

GLOBAL MARKETS-Vaccine progress lift stocks, dollar still sickly

* AstraZeneca vaccine returns stocks to February levels* Australia eases lockdowns, U.S. vaccines in sight* 2020 asset performance http://tmsnrt.rs/2yaDPgn* World FX rates in 2020 http://tmsnrt.rs/2egbfVh*By Lawrence White and Andrew GalbraithLONDON/...

Read more
23 Nov 2020 09:51

AstraZeneca to discuss with U.S. FDA changing vaccine trial design

LONDON, Nov 23 (Reuters) - AstraZeneca will start discussions this week with the U.S. Food and Drug Administration (FDA) to change the design of its experimental COVID-19 vaccine trial to add a likely more effective dosage regime, a senior execut...

Read more
23 Nov 2020 09:49

UPDATE 1-AstraZeneca will have enough COVID-19 vaccine for 200 mln doses this year

(Adds detail)LONDON, Nov 23 (Reuters) - AstraZeneca will have enough of its candidate vaccine for 200 million doses by the end of 2020, with drug substance for 700 million doses by the end of the first quarter of 2021 globally, operations executiv...

Read more
23 Nov 2020 09:45

UPDATE 2-Sterling hits 2-1/2-month high on vaccine and Brexit deal optimism

* Pound hits 2-1/2-month high vs dollar* Forecast-beating PMIs support sterling* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv (Adds new quote, latest prices)LON...

Read more
23 Nov 2020 09:45

UPDATE 1-Sterling rallies on vaccine and Brexit deal optimism

* Pound hits 2-1/2 month high vs dollar* Forecast-beating PMIs support sterling* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv (Adds details after PMI release, c...

Read more
23 Nov 2020 09:25

Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virus

LONDON, Nov 23 (Reuters) - The experimental COVID-19 vaccine developed by AstraZeneca and Oxford University would have a higher efficacy rate if trials were only measuring whether the shot prevents hospitalisation and severe disease, Oxford's vac...

Read more
23 Nov 2020 09:23

Sterling rallies on vaccine and Brexit deal optimism

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9HvLONDON, Nov 23 (Reuters) - Sterling rallied on Monday as more positive news about a potential COVID-19 vaccine pro...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.